GO:0050661 NADP binding: Mechanism, Genes and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0050661 (NADP binding) is a molecular function describing binding to nicotinamide-adenine dinucleotide phosphate, either oxidized NADP+ or reduced NADPH.
• NADP-dependent enzymes share a conserved dinucleotide-binding fold and stereochemistry of cofactor binding, as shown by structural analysis of multiple oxidoreductases.
• Key NADP-binding proteins include glucose-6-phosphate dehydrogenase (G6PD), ferredoxin-NADP+ reductase (FNR), adrenodoxin reductase, and YqhD, each with distinct physiological roles.
• NADP binding is dynamic: NMR and crystallographic studies reveal conformational changes and cofactor release mechanisms in enzymes such as E. coli YqhD and bacterial FNR.
• Mutations affecting NADP binding can alter enzyme stability, folding, and catalytic efficiency, with implications for drug design and metabolic engineering.
• CRISPR-based knockout, point mutation, and knock-in models enable functional dissection of NADP-binding sites in disease-relevant genes.
Description
NADP binding (GO:0050661) is a fundamental molecular function that underpins numerous redox and biosynthetic reactions in all domains of life. The coenzyme nicotinamide-adenine dinucleotide phosphate (NADP) exists in oxidized (NADP+) and reduced (NADPH) forms, and proteins that bind it participate in processes ranging from antioxidant defense to steroidogenesis and photosynthesis. Understanding the structural and mechanistic basis of NADP binding is essential for researchers studying metabolic disorders, infectious diseases, and cancer. This article integrates authoritative QuickGO annotation with published structural and biochemical studies to provide a research-grade overview of NADP binding, its key genes, and experimental approaches for functional interrogation.
NADP binding At A Glance
| GO ID | GO:0050661 |
|---|---|
| GO term | NADP binding |
| Ontology | molecular_function |
| Synonym | NADP or NADPH binding; NADP+ or NADPH binding; nicotinamide adenine dinucleotide phosphate binding |
| Major function | Binding to NADP+ or NADPH, enabling redox catalysis, biosynthetic reactions, and regulatory sensing |
| Conserved structural motif | Dinucleotide-binding fold (Rossmann fold) with conserved stereochemistry |
| Representative enzymes | G6PD, FNR, adrenodoxin reductase, YqhD |
| Dynamic behavior | Cofactor binding/release can involve conformational changes and allosteric regulation |
What Is GO:0050661?
According to the Gene Ontology, GO:0050661 (NADP binding) is defined as the binding to nicotinamide-adenine dinucleotide phosphate, a coenzyme involved in many redox and biosynthetic reactions; binding may be to either the oxidized form, NADP+, or the reduced form, NADPH. This molecular function is mediated by specific structural motifs, often a Rossmann-like fold, that coordinate the dinucleotide phosphate moiety. The term encompasses both transient and stable interactions, as observed in enzymes, regulatory proteins, and sensor domains.
Why Is NADP binding Important in Cell Biology?
NADP binding is central to cellular redox homeostasis, biosynthesis, and detoxification. Proteins that bind NADP/NADPH are involved in pathways such as the pentose phosphate pathway, steroid hormone synthesis, and photosynthetic electron transport. Dysregulation of NADP-binding enzymes is linked to human diseases including hemolytic anemia, cancer, and neurodegeneration. Moreover, the conserved nature of NADP-binding folds makes them attractive targets for drug discovery and metabolic engineering.
• NADPH is a major cellular reducing agent; NADP-binding enzymes maintain redox balance.
• G6PD, a key NADP-binding enzyme, is essential for antioxidant defense in red blood cells.
• Ferredoxin-NADP+ reductase (FNR) is critical for photosynthesis and nitrogen fixation.
• Adrenodoxin reductase, an NADP-binding flavoprotein, participates in steroid hormone biosynthesis.
• NADP(H) sensor proteins regulate gene expression in response to redox state.
• Mutations in NADP-binding sites can cause enzyme deficiency and metabolic disorders.
• NADP-binding enzymes are targets for antiparasitic and anticancer drugs.
• Understanding NADP binding aids in engineering enzymes with altered cofactor specificity.
What Happens During NADP binding?
Cofactor recognition and initial binding
In simple terms: The protein recognizes and grabs the NADP molecule.
NADP binding begins with specific interactions between the protein and the adenine, nicotinamide, and phosphate moieties of NADP+ or NADPH. Structural studies of human G6PD show that the cofactor binds in a cleft with conserved residues forming hydrogen bonds and hydrophobic contacts. In E. coli YqhD, molecular dynamics simulations reveal a dynamic preference for NADP/H binding and release, indicating that initial recognition is flexible.
Conformational changes and cofactor positioning
In simple terms: The protein changes shape to hold the cofactor in the right position.
Upon binding, many NADP-dependent enzymes undergo conformational rearrangements that position the nicotinamide ring for catalysis. For example, bacterial ferredoxin-NADP+ reductases exhibit a particular NADP+ binding mode that induces a new catalytic mechanism. Similarly, the NADP(H) sensor protein Rex undergoes a restructuring of its dinucleotide-binding fold upon NADP binding, which modulates DNA binding.
Catalysis and redox chemistry
In simple terms: The cofactor helps transfer electrons or hydride ions in chemical reactions.
Once bound, NADP+ or NADPH participates directly in redox reactions. In G6PD, NADP+ binding is essential for the oxidation of glucose-6-phosphate, producing NADPH. Ferredoxin-NADP+ reductase transfers electrons from ferredoxin to NADP+, generating NADPH for biosynthetic processes. The conserved stereochemistry of cofactor binding ensures precise hydride transfer.
Cofactor release and recycling
In simple terms: The cofactor leaves the protein so it can be reused.
After catalysis, NADP+ or NADPH is released, allowing the enzyme to turnover. Studies on YqhD show that NADP/H release is dynamic and can be rate-limiting. In FNR, the binding affinity and release kinetics are modulated by interactions with partner proteins such as photosystem I.
Regulation by cellular redox state
In simple terms: The cell's redox balance controls how much NADP binds.
The availability of NADP+ versus NADPH influences binding and enzyme activity. Sensor proteins like Rex detect changes in NADP(H) levels and regulate gene expression accordingly. This feedback ensures metabolic homeostasis.
Key Genes Involved in GO:0050661 NADP binding
The following genes encode proteins with experimentally validated NADP binding activity, as supported by structural and biochemical studies.
| Gene | Major Role | Research Relevance |
|---|---|---|
| G6PD | Glucose-6-phosphate dehydrogenase; produces NADPH for antioxidant defense | Mutations cause G6PD deficiency; target for antimalarial drugs |
| FNR | Ferredoxin-NADP+ reductase; photosynthetic electron transfer | Key for photosynthesis and nitrogen fixation; model for cofactor binding |
| FDXR | Adrenodoxin reductase; mitochondrial steroidogenesis | Mutations linked to adrenal insufficiency; NADP-binding site identified |
| YqhD | E. coli NADP-dependent oxidoreductase; detoxifies aldehydes | Model for dynamic cofactor binding and release |
| Rex | NADP(H) sensor protein; regulates gene expression | Structural paradigm for NADP-induced conformational change |
| ME1 | Malic enzyme 1; generates NADPH for lipogenesis | Overexpressed in cancers; NADP binding essential for activity |
| IDH1 | Isocitrate dehydrogenase 1; produces NADPH | Mutations in cancer alter NADP binding and activity |
| IDH2 | Isocitrate dehydrogenase 2; mitochondrial NADPH production | Mutations in leukemia and gliomas affect NADP binding |
| MTHFD1 | Methylenetetrahydrofolate dehydrogenase; NADP-dependent | Involved in folate metabolism; NADP binding critical |
| ALDH1A1 | Aldehyde dehydrogenase; NADP-dependent oxidation | Cancer stem cell marker; NADP binding for retinoic acid synthesis |
| NNT | Nicotinamide nucleotide transhydrogenase; NADP(H) binding | Maintains mitochondrial redox; mutations affect steroidogenesis |
| GR | Glutathione reductase; uses NADPH to reduce glutathione | NADP binding essential for antioxidant defense |
| TrxR | Thioredoxin reductase; NADPH-dependent | Target for cancer therapy; NADP binding required |
| CBR1 | Carbonyl reductase 1; NADPH-dependent | Metabolizes drugs; NADP binding affects efficacy |
| AKR1B1 | Aldose reductase; NADPH-dependent | Implicated in diabetic complications; NADP binding site studied |
| PTGR1 | Prostaglandin reductase 1; NADP(H)-dependent | Role in inflammation and cancer; NADP binding relevant |
| BLVRB | Biliverdin reductase B; NADPH-dependent | Redox regulation; NADP binding characterized |
How Is NADP binding Regulated?
NADP binding is regulated at multiple levels. The cellular ratio of NADP+ to NADPH directly affects cofactor occupancy and enzyme activity. Post-translational modifications, such as phosphorylation, can modulate NADP binding affinity. In some enzymes, partner proteins or substrate availability induce conformational changes that alter NADP binding. Additionally, expression levels of NADP-binding enzymes are controlled transcriptionally in response to oxidative stress and metabolic demands.
NADP binding and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| G6PD | G6PD deficiency, hemolytic anemia | Knock-in of patient mutations in erythroid cell lines |
| IDH1 | Glioma, acute myeloid leukemia | Point mutation knock-in in cancer cell lines |
| FDXR | Adrenal insufficiency, neuropathy | Knockout and point mutation in adrenal cell models |
| ME1 | Cancer metabolism | Overexpression and knockout in cancer cell lines |
| NNT | Mitochondrial redox imbalance | Knockout in steroidogenic cells |
G6PD deficiency and hemolytic anemia
Mutations in G6PD that impair NADP binding reduce NADPH production, leading to oxidative damage and hemolysis. Structural studies have elucidated how NADP+ binds to human G6PD and how mutations affect stability and folding. This has implications for understanding drug-induced hemolysis and for developing new antimalarials.
Cancer metabolism and IDH mutations
Isocitrate dehydrogenase (IDH1/IDH2) mutations alter NADP binding and confer neomorphic activity, producing 2-hydroxyglutarate, which contributes to oncogenesis. Targeting NADP binding in metabolic enzymes is a promising anticancer strategy.
Mitochondrial steroidogenesis disorders
Adrenodoxin reductase (FDXR) mutations affecting NADP binding cause mitochondrial steroidogenesis defects, leading to adrenal insufficiency and neurological symptoms. Understanding the NADP-binding site aids in diagnosis and potential therapies.
From NADP binding-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does loss of NADP binding affect enzyme activity? | Knockout of the gene in a relevant cell line |
| How does a specific point mutation alter NADP binding affinity? | Point mutation knock-in using CRISPR |
| Can a disease-associated mutation be corrected? | Knock-in of wild-type allele |
| Where is the NADP-binding protein localized? | Tagged knock-in with fluorescent protein |
| What is the effect of NADP-binding protein overexpression? | Overexpression via lentiviral transduction |
| Which genes interact with NADP-binding proteins? | CRISPR library screening |
How to Study the NADP binding Process
| Method | What It Measures | Typical Application |
|---|---|---|
| X-ray crystallography | 3D structure of protein-NADP complex | Determine binding mode and conformational changes |
| Cryo-EM | Structure of large complexes with NADP | Study membrane-bound or large NADP-binding complexes |
| ITC | Binding affinity (Kd) and thermodynamics | Quantify NADP binding to purified proteins |
| SPR | Binding kinetics (kon, koff) | Compare mutant vs wild-type binding |
| Molecular dynamics | Dynamic binding and release | Simulate cofactor movement |
| Site-directed mutagenesis | Effect of specific residues on binding | Identify key NADP-binding residues |
| Enzymatic activity assay | Catalytic function dependent on NADP | Measure impact of mutations on activity |
| CRISPR screening | Genes affecting NADP-dependent pathways | Identify synthetic lethal interactions |
Structural biology (X-ray crystallography and cryo-EM)
Crystallography and cryo-EM reveal the atomic details of NADP binding, including conserved folds and conformational changes. For example, the structure of human G6PD with NADP+ provided insights into cofactor binding and mutations. FNR binding to photosystem I was studied by structural methods.
Biochemical binding assays
Isothermal titration calorimetry (ITC) and surface plasmon resonance (SPR) measure binding affinity and kinetics. These techniques have been used to characterize NADP binding to YqhD and G6PD.
Molecular dynamics simulations
Computational simulations capture dynamic binding and release of NADP/H, as demonstrated for E. coli YqhD. They complement static structures and reveal transient interactions.
Mutagenesis and functional assays
Site-directed mutagenesis of NADP-binding residues, followed by enzymatic activity assays, identifies critical residues. This approach has been used to study FNR and G6PD.
How CRISPR Can Be Used to Study GO:0050661 NADP binding
Knockout
CRISPR knockout of NADP-binding genes (e.g., G6PD, IDH1) enables loss-of-function studies to assess their role in metabolism, redox balance, and disease. For example, G6PD knockout cells show increased oxidative stress.
Point Mutation
Introducing specific point mutations in NADP-binding sites (e.g., G6PD mutations) via CRISPR allows precise modeling of disease-associated variants and analysis of cofactor binding affinity.
Knock-in
Knock-in of wild-type or tagged NADP-binding proteins can rescue knockout phenotypes or enable localization studies. Tagged knock-in of FNR has been used to study its interaction with photosystem I.
Overexpression
CRISPR activation (CRISPRa) or lentiviral overexpression of NADP-binding enzymes (e.g., ME1) can probe gain-of-function effects in cancer metabolism and identify dependencies.
How EDITGENE Supports NADP binding Research
Researchers studying NADP binding-related genes often need to determine whether a candidate gene is causally involved in a specific pathway or disease. EDITGENE provides comprehensive CRISPR-based services to generate precisely engineered cell models, enabling functional validation of NADP-binding proteins.
Contact EDITGENE today to design your custom CRISPR model for NADP binding research.
Related Products
| Product name | Cat.No. | Species | Gene ID | |
|---|---|---|---|---|
| NOS3 Knockout HEK293 Cell Line | EDJ-KQ840 | Human | 4846 | Details Get a Quote |
| NOS1 Knockout HEK293 Cell Line | EDJ-KQ844 | Human | 4842 | Details Get a Quote |
| NOS2 Knockout HEK293 Cell Line | EDJ-KQ1428 | Human | 4843 | Details Get a Quote |
| CAT Knockout HEK293 Cell Line | EDJ-KQ1543 | Human | 847 | Details Get a Quote |
| DHCR7 Knockout HEK293 Cell Line | EDJ-KQ1955 | Human | 1717 | Details Get a Quote |
| HIBADH Knockout HEK293 Cell Line | EDJ-KQ2273 | Human | 11112 | Details Get a Quote |
| HSD11B1 Knockout HEK293 Cell Line | EDJ-KQ2543 | Human | 3290 | Details Get a Quote |
| GLYR1 Knockout HEK293 Cell Line | EDJ-KQ2651 | Human | 84656 | Details Get a Quote |
| POR Knockout HEK293 Cell Line | EDJ-KQ3088 | Human | 5447 | Details Get a Quote |
| GSR Knockout HEK293 Cell Line | EDJ-KQ3546 | Human | 2936 | Details Get a Quote |
| CRYM Knockout HEK293 Cell Line | EDJ-KQ4359 | Human | 1428 | Details Get a Quote |
| DPYD Knockout HEK293 Cell Line | EDJ-KQ4478 | Human | 1806 | Details Get a Quote |
| FMO1 Knockout HEK293 Cell Line | EDJ-KQ4614 | Human | 2326 | Details Get a Quote |
| FMO2 Knockout HEK293 Cell Line | EDJ-KQ4615 | Human | 2327 | Details Get a Quote |
| FMO3 Knockout HEK293 Cell Line | EDJ-KQ4616 | Human | 2328 | Details Get a Quote |
- 1
- 2
- Next Page »
Frequently Asked Questions About NADP binding
What is NADP binding?
NADP binding (GO:0050661) is a molecular function where a protein binds to nicotinamide-adenine dinucleotide phosphate, either in its oxidized (NADP+) or reduced (NADPH) form, to facilitate redox reactions and biosynthesis.
What genes are involved in NADP binding?
Key genes include G6PD, FNR, FDXR, YqhD, Rex, IDH1, IDH2, ME1, and many dehydrogenases and reductases.
What is the GO term for NADP binding?
The Gene Ontology term is GO:0050661, officially named NADP binding, under the molecular_function ontology.
How does NADP binding affect enzyme activity?
NADP binding positions the cofactor for hydride transfer, and mutations that alter binding can reduce catalytic efficiency or change substrate specificity.
What diseases are associated with NADP binding defects?
Defects in NADP-binding enzymes are linked to G6PD deficiency, hemolytic anemia, cancer (IDH mutations), and mitochondrial steroidogenesis disorders.
What is the difference between NADP+ and NADPH binding?
NADP+ is the oxidized form and NADPH is the reduced form; both can bind to proteins, but they participate in different redox reactions.
How can I study NADP binding in the lab?
Common methods include X-ray crystallography, ITC, SPR, molecular dynamics, mutagenesis, and enzymatic assays.
What is the conserved structure of NADP-binding proteins?
Many NADP-binding proteins share a Rossmann-like dinucleotide-binding fold with conserved stereochemistry.
Can CRISPR be used to study NADP binding?
Yes, CRISPR knockout, point mutation, and knock-in models allow precise functional analysis of NADP-binding sites in cells.
What is the role of NADP binding in cancer?
NADP binding is critical for metabolic enzymes like IDH1/2 and ME1, which support cancer cell growth and redox balance.
Conclusion
NADP binding (GO:0050661) is a cornerstone molecular function that enables diverse redox and biosynthetic processes. Structural and biochemical studies have revealed conserved binding folds and dynamic mechanisms, while disease associations highlight its clinical relevance. CRISPR-based models provide powerful tools to dissect the functional consequences of NADP-binding alterations, paving the way for new therapeutic strategies.
References
- 1. Verma R et al.. 2021. Dynamic Preference for NADP/H Cofactor Binding/Release in E. coli YqhD Oxidoreductase.. Molecules 26(2) PMID: 33430436
- 2. Marco P et al.. 2019. Binding of ferredoxin NADP(+) oxidoreductase (FNR) to plant photosystem I.. Biochim Biophys Acta Bioenerg 1860(9):689-698 PMID: 31336103
- 3. Verma A et al.. 2016. NADP⁺ binding effects tryptophan accessibility, folding and stability of recombinant B. malayi G6PD.. Int J Biol Macromol 85:645-54 PMID: 26763177
- 4. Carugo O et al.. 1997. NADP-dependent enzymes. I: Conserved stereochemistry of cofactor binding.. Proteins 28(1):10-28 PMID: 9144787
- 5. Monchietti P et al.. 2021. A new catalytic mechanism of bacterial ferredoxin-NADP(+) reductases due to a particular NADP(+) binding mode.. Protein Sci 30(10):2106-2120 PMID: 34382711
- 6. Hanukoglu I et al.. 1989. cDNA sequence of adrenodoxin reductase. Identification of NADP-binding sites in oxidoreductases.. Eur J Biochem 180(2):479-84 PMID: 2924777
- 7. Zheng X et al.. 2007. Restructuring of the dinucleotide-binding fold in an NADP(H) sensor protein.. Proc Natl Acad Sci U S A 104(21):8809-14 PMID: 17496144
- 8. Kotaka M et al.. 2005. Structural studies of glucose-6-phosphate and NADP+ binding to human glucose-6-phosphate dehydrogenase.. Acta Crystallogr D Biol Crystallogr 61(Pt 5):495-504 PMID: 15858258
